These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7784000)
1. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation. Thorp JA; Ferrette-Smith D; Gaston LA; Johnson J; Yeast JD; Meyer B Obstet Gynecol; 1995 Jul; 86(1):1-8. PubMed ID: 7784000 [TBL] [Abstract][Full Text] [Related]
2. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial. Thorp JA; Parriott J; Ferrette-Smith D; Meyer BA; Cohen GR; Johnson J Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312 [TBL] [Abstract][Full Text] [Related]
3. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. Liu J; Wang Q; Zhao JH; Chen YH; Qin GL J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657 [TBL] [Abstract][Full Text] [Related]
4. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation. Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353 [TBL] [Abstract][Full Text] [Related]
5. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants. Liu J; Wang Q; Gao F; He JW; Zhao JH J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625 [TBL] [Abstract][Full Text] [Related]
6. Does perinatal phenobarbital exposure affect developmental outcome at age 2? Thorp JA; O'Connor M; Jones AM; Hoffman EL; Belden B Am J Perinatol; 1999; 16(2):51-60. PubMed ID: 10355910 [TBL] [Abstract][Full Text] [Related]
7. Use of prenatal phenobarbital in the prevention of subependymal/intraventricular hemorrhage in premature infants. Arroyo-Cabrales LM; Garza-Morales S; Hernández-Peláez G Arch Med Res; 1998; 29(3):247-51. PubMed ID: 9775459 [TBL] [Abstract][Full Text] [Related]
8. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study]. Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029 [TBL] [Abstract][Full Text] [Related]
9. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage. Pomerance JJ; Teal JG; Gogolok JF; Brown S; Stewart ME Obstet Gynecol; 1987 Aug; 70(2):235-41. PubMed ID: 3601288 [TBL] [Abstract][Full Text] [Related]
10. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Kazzi NJ; Ilagan NB; Liang KC; Kazzi GM; Poland RL; Grietsell LA; Fujii Y; Brans YW Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133 [TBL] [Abstract][Full Text] [Related]
11. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. Shankaran S; Papile LA; Wright LL; Ehrenkranz RA; Mele L; Lemons JA; Korones SB; Stevenson DK; Donovan EF; Stoll BJ; Fanaroff AA; Oh W N Engl J Med; 1997 Aug; 337(7):466-71. PubMed ID: 9250849 [TBL] [Abstract][Full Text] [Related]
12. Perinatal factors associated with severe intracranial hemorrhage. Thorp JA; Jones PG; Clark RH; Knox E; Peabody JL Am J Obstet Gynecol; 2001 Oct; 185(4):859-62. PubMed ID: 11641666 [TBL] [Abstract][Full Text] [Related]
15. Antenatal corticosteroid therapy in premature infants. Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401 [TBL] [Abstract][Full Text] [Related]
16. Survival and short-term morbidity of the premature neonate. Gilstrap LC; Hauth JC; Bell RE; Ackerman NB; Yoder BA; Delemos R Obstet Gynecol; 1985 Jan; 65(1):37-41. PubMed ID: 3838111 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Vermillion ST; Soper DE; Bland ML; Newman RB Am J Obstet Gynecol; 2000 Oct; 183(4):925-9. PubMed ID: 11035339 [TBL] [Abstract][Full Text] [Related]
18. Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes. Lee MJ; Davies J; Guinn D; Sullivan L; Atkinson MW; McGregor S; Parilla BV; Hanlon-Lundberg K; Simpson L; Stone J; Wing D; Ogasawara K; Muraskas J Obstet Gynecol; 2004 Feb; 103(2):274-81. PubMed ID: 14754695 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825 [TBL] [Abstract][Full Text] [Related]
20. Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants. Klinger G; Koren G Can Fam Physician; 2000 Jun; 46():1285-7. PubMed ID: 10907564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]